Facing rival drugs, Novartis gets win with Afinitor in Europe

ZURICH, June 2 (Reuters) - Efforts by Novartis to

defend its blockbuster cancer drug Afinitor against competitors

got a boost on Thursday from European regulators, who approved

it for use on certain...

Read more